Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1167421-25-1 | (2S)-2-amino-6-{[(2-azidoethoxy)carbonyl]amino}hexanoic acid | AA0096OC | MFCD22393077
1131737-01-3 | 2-Butanamine, 1,1,1-trifluoro-3-methyl-, (2S)- | AA0096ZV | MFCD04972666
118724-99-5 | 2-(2-Acetamido-2-methylpropanamido)-2-methylpropanoic acid | AA0097QV | MFCD18824104
1103926-82-4 | TM 5275 | AA0097DG | MFCD28396414
1160246-87-6 | 2-(8-(tert-Butoxycarbonyl)-1-oxa-8-azaspiro-[4.5]decan-3-yl)acetic acid | AA0099FD | MFCD12198525
1048640-87-4 | (4-Methoxybenzyl)(tetrahydro-2-furanylmethyl)amine hydrochloride | AA0099UN | MFCD03930962
139911-30-1 | 2-Chloro-5-fluoronicotinic acid ethyl ester | AA009AFD | MFCD23103604
1217741-88-2 | Fmoc-(s)-3-amino-3-(2-furyl)-propionic acid | AA009AVP | MFCD04117841
134388-88-8 | 3-Ethyl 2-Methyl 6-hydroxy-3,4-dihydroisoquinoline-2,3(1H)-dicarboxylate | AA009B2W | MFCD11505031
128218-53-1 | 4-METHYLUMBELLIFERYL PHOSPHATE, BIS(CYCLOHEXYLAMMONIUM) SALT | AA009BGJ | MFCD00153293
40235-65-2
74686-78-5
883545-53-7
2070896-29-4
392292-34-1
1269294-32-7